Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| U1111-1266-5484 | Other Identifier | World Health Organization (WHO) |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
ACTION APAC is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment options or pharmaceutical product. Collection of data will be performed via quantitative online survey by a third-party vendor through existing databases/panels in APAC region.
The goal of this study is to provide insights to drive awareness around the needs of People Living with Obesity (PLwO) and Health Care Professionals (HCPs) involved in obesity treatment and management.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| People / Person Living with Obesity (PLwO) | From online, general population consumer panels |
| |
| Health Care Professionals (HCPs) | HCPs treating people who have obesity |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| No treatment given | Other | No treatment given |
|
| Measure | Description | Time Frame |
|---|---|---|
| Weight loss motivators for improving health of PLwO | Multi-select from defined list | At the time of survey response (Day 1) |
| Weight loss barriers for improving health of PLwO | Multi-select from defined list | At the time of survey response (Day 1) |
| Weight loss management for improving health of PLwO | Multi-select from defined list | At the time of survey response (Day 1) |
| Weight loss responsibility for improving health of PLwO | Multi-select from defined list | At the time of survey response (Day 1) |
| Proportion of PLwO who made serious weight loss effort | Number of weight loss efforts; percentage of patients | At the time of survey response (Day 1) |
| Response to weight loss discussions | Single select from defined list | At the time of survey response (Day 1) |
| Attitudes towards obesity and weight management and Interactions of PLwOs with HCPs | 5-point Likert scales | At the time of survey response (Day 1) |
Not provided
Not provided
Inclusion criteria:
People Living with Obesity
Health Care Professionals
Exclusion criteria:
People Living with obesity
Health Care Providers
Not provided
Not provided
Not provided
The respondent population will include people living with obesity (PLwO) and health care professionals (HCPs) involved in obesity treatment and management.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Clinical Transparency (dept. 2834) | Novo Nordisk A/S | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Novo Nordisk Investigational Site | Dhaka | Bangladesh | ||||
| Novo Nordisk Investigational Site |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 39101238 | Derived | Unnikrishnan AG, Chowdhury S, Garcia MM, Jain RK, John M, Lakdawala M, Pai R, Suresh SH, Rahman SK. Perceptions, attitudes and barriers to effective obesity care among people with obesity and health care professionals in India. Diabetes Obes Metab. 2024 Oct;26(10):4791-4794. doi: 10.1111/dom.15824. Epub 2024 Aug 5. No abstract available. |
Not provided
Not provided
According to the Novo Nordisk disclosure commitment on novonordisk-trials.com
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009765 | Obesity |
| ID | Term |
|---|---|
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Bangalore |
| India |
| Novo Nordisk Investigational Site | Jakarta | Indonesia |
| Novo Nordisk Investigational Site | Kuala Lumpur | Malaysia |
| Novo Nordisk Investigational Site | Karachi | Pakistan |
| Novo Nordisk Investigational Site | Manila | Philippines |
| Novo Nordisk Investigational Site | Singapore | Singapore |
| Novo Nordisk Investigational Site | Bangkok | Thailand |
| Novo Nordisk Investigational Site | Ho Chi Minh City | Vietnam |
| D001835 |
| Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |